Publicaciones - IR Sant Pau

Buscar

01/11/2024 Testicular cancer in Ibero-America: Proper prevention and diagnostic strategies

Ebel, L, Autrán, AM, Rodríguez-Faba, O, Alcántara, C. Testicular cancer in Ibero-America: Proper prevention and diagnostic strategies. Actas Urologicas Espanolas. 2024; 48(9)DOI:10.1016/j.acuro.2024.05.004. PMID:38848949. IF:1.200(Q3/7D).

01/11/2024 Cumulative morbidity of ureteroscopy for upper tract urothelial carcinoma

Basile, G, Gallioli, A, Territo, A, Verri, P, Gaya, JM, Afferi, L, Diana, P, Sanz, I, Dieguez, L, Uleri, A, Berquin, C, Gavrilov, P, Algaba, F, Palou, J, Breda, A. Cumulative morbidity of ureteroscopy for upper tract urothelial carcinoma. Actas Urologicas Espanolas. 2024; 48(9)DOI:10.1016/j.acuro.2024.02.007. PMID:38735432. IF:1.200(Q3/7D).

01/11/2024 Social media and urology: The good, the bad and the ugly

Juliebo-Jones, P, Gauhar, V, Keller, EX, De Coninck, V, Talyshinskii, A, Sierra, A, Ventimiglia, E, Tzelves, L, Corrales, M, Emiliani, E, Beisland, C, Somani, BK. Social media and urology: The good, the bad and the ugly. Urologia Journal. 2024; 91(4)DOI:10.1177/03915603241273885. PMID:39212156. IF:(Q/D).

01/11/2024 The infection post flexible UreteroreNoscopy (I-FUN) predictive model based on machine learning: a new clinical tool to assess the risk of sepsis post retrograde intrarenal surgery for kidney stone disease

Castellani, D, De Stefano, V, Brocca, C, Mazzon, G, Celia, A, Bosio, A, Gozzo, C, Alessandria, E, Cormio, L, Ratnayake, R, Fugini, AV, Morena, T, Tanidir, Y, Sener, TE, Choong, S, Ferretti, S, Pescuma, A, Micali, S, Pavan, N, Simonato, A, Miano, R, Orecchia, L, Pirola, GM, Naselli, A, Emiliani, E, Hernandez-Peñalver, P, Di Dio, M, Bisegna, C, Campobasso, D, Serafin, E, Antonelli, A, Rubilotta, E, Ragoori, D, Balloni, E, Paolanti, M, Gauhar, V, Galosi, AB. The infection post flexible UreteroreNoscopy (I-FUN) predictive model based on machine learning: a new clinical tool to assess the risk of sepsis post retrograde intrarenal surgery for kidney stone disease. WORLD JOURNAL OF UROLOGY. 2024; 42(1)DOI:10.1007/s00345-024-05314-5. PMID:39485570. IF:2.900(Q2/3D).

01/11/2024 p53 Immunohistochemistry Defines a Subset of Human Papillomavirus-Independent Penile Squamous Cell Carcinomas With Adverse Prognosis.

Trias I, Algaba F, de Torres I, Saco A, Marimon L, Peñuelas N, Diez-Ahijado L, Sisuashvili L, Darecka K, Morató A, Del Pino M, Ferrándiz-Pulido C, Ribal MJ, Ajami T, Corral JM, Gaya JM, Reig O, Ordi O, Ribera-Cortada I, García-Herrera A, Rakislova N. p53 Immunohistochemistry Defines a Subset of Human Papillomavirus-Independent Penile Squamous Cell Carcinomas With Adverse Prognosis.. AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2024; 48(11)DOI:10.1097/PAS.0000000000002291. PMID:39040011. IF:(Q/D).

01/11/2024 Mortality, perioperative complications and surgical timelines in hip fracture patients: Comparison of the Spanish with the non-Spanish Cohort of the HIP ATTACK-1 trial

Guerra-Farfan, E, Borges, FK, Bhandari, M, Garcia-Sanchez, Y, Nuoez, JH, Mestre-Torres, J, Tomas-Hernandez, J, Teixidor-Serra, J, Balaguer-Castro, M, Castillon, P, Dealbert, A, Rodriguez, JD, Aguado, HJ, Guerado, E, Popova, E, Tonelli, AC, Balasubramanian, K, Vincent, J, Harvey, V, Kocaqi, E, Slobogean, G, Devereaux, PJ. Mortality, perioperative complications and surgical timelines in hip fracture patients: Comparison of the Spanish with the non-Spanish Cohort of the HIP ATTACK-1 trial. INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED. 2024; 55(11)DOI:10.1016/j.injury.2024.111827. PMID:39217648. IF:2.000(Q2/4D).

01/11/2024 Biomarkers of Frailty in Patients with Advanced Chronic Liver Disease Undergoing a Multifactorial Intervention Consisting of Home Exercise, Branched-Chain Amino Acids, and Probiotics

Laghi, L, Ortiz, MA, Rossi, G, Román, E, Mengucci, C, Cantó, E, Biagini, L, Sánchez, E, Mulet, M, García-Osuna, A, Urgell, E, Kaur, N, Poca, M, Padrós, J, Nadal, MJ, Cuyàs, B, Alvarado, E, Vidal, S, Juanes, E, Ferrero-Gregori, A, Escorsell, A, Soriano, G. Biomarkers of Frailty in Patients with Advanced Chronic Liver Disease Undergoing a Multifactorial Intervention Consisting of Home Exercise, Branched-Chain Amino Acids, and Probiotics. Biomolecules. 2024; 14(11)DOI:10.3390/biom14111410. PMID:39595586. IF:4.800(Q1/3D).

01/11/2024 Impact of Overnight Storage of Human Atrial Myocytes on Intracellular Calcium Homeostasis and Electrophysiological Utility

Aceituno, C, Revuelta, D, Jiménez-Sábado, V, Ginel, A, Molina, CE, Hove-Madsen, L. Impact of Overnight Storage of Human Atrial Myocytes on Intracellular Calcium Homeostasis and Electrophysiological Utility. Biomolecules. 2024; 14(11)DOI:10.3390/biom14111415. PMID:39595591. IF:4.800(Q1/3D).

01/11/2024 Percutaneous Transhepatic Cholangioscopy in the Management of Hepatolithiasis

Arnau, ABM, Espelt, AM, Auñon, JV, Sánchez-Cabús, S. Percutaneous Transhepatic Cholangioscopy in the Management of Hepatolithiasis. CIRUGIA ESPANOLA. 2024; 102(11)DOI:10.1016/j.ciresp.2024.06.009. PMID:. IF:1.300(Q3/7D).

01/11/2024 A Study of the Relationship Between Objective Tests to Diagnose Erectile Dysfunction and Markers of Cardiovascular Disease

Ponce, MD, Schwieters, CFQ, Meziere, J, Curbelo, JRS, Carratala, GA, Troka, E, Arnau, LB, Castañé, ER, Barcina, MJM, Rajmil, O. A Study of the Relationship Between Objective Tests to Diagnose Erectile Dysfunction and Markers of Cardiovascular Disease. Journal of Clinical Medicine. 2024; 13(21)DOI:10.3390/jcm13216321. PMID:39518460. IF:2.900(Q1/2D).

01/11/2024 Burden of Mitral Regurgitation in Spain from 2016-2021: An Analysis by Aetiology and Sex

Zamorano, JL, Alvarez-Bartolomé, M, Arzamendi, D, Carnero-Alcázar, M, Cruz-González, I, Li, CHP, Pardo-Sanz, A, Martínez-Pérez, O, Cerezales, M, Cuervo, J, Vernia, M, González, P, Martí-Sánchez, B. Burden of Mitral Regurgitation in Spain from 2016-2021: An Analysis by Aetiology and Sex. Journal of Clinical Medicine. 2024; 13(21)DOI:10.3390/jcm13216372. PMID:39518512. IF:2.900(Q1/2D).

01/11/2024 Advances in the Assessment of Patients With Tricuspid Regurgitation: A State-of-the-Art Review on the Echocardiographic Evaluation Before and After Tricuspid Valve Interventions

Badano, LP, Tomaselli, M, Muraru, D, Galloo, X, Li, CHP, Marsan, NA. Advances in the Assessment of Patients With Tricuspid Regurgitation: A State-of-the-Art Review on the Echocardiographic Evaluation Before and After Tricuspid Valve Interventions. JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY. 2024; 37(11)DOI:10.1016/j.echo.2024.07.008. PMID:39029717. IF:6.000(Q1/2D).

01/11/2024 Spanish heart transplant registry. 35th official report of the Heart Failure Association of the Spanish Society of Cardiology

González-Vílchez, F, Almenar-Bonet, L, Mitroi, C, Crespo-Leiro, MG, López-Granados, A, Valero, M, Delgado-Jiménez, JF, Mirabet-Pérez, S, Sobrino-Márquez, JM, García-Romeroo, E. Spanish heart transplant registry. 35th official report of the Heart Failure Association of the Spanish Society of Cardiology. REVISTA ESPANOLA DE CARDIOLOGIA. 2024; 77(11)DOI:10.1016/j.rec.2024.05.015. PMID:39032818. IF:4.900(Q1/2D).

01/11/2024 Spanish cardiac catheterization and coronary intervention registry. 33rd official report of the Interventional Cardiology Association of the Spanish Society of Cardiology (1990-2023)

Bastante, T, Arzamendi, D, Martín-Moreiras, J, Alvarez, ABC. Spanish cardiac catheterization and coronary intervention registry. 33rd official report of the Interventional Cardiology Association of the Spanish Society of Cardiology (1990-2023). REVISTA ESPANOLA DE CARDIOLOGIA. 2024; 77(11)DOI:10.1016/j.rec.2024.07.015. PMID:39332624. IF:4.900(Q1/2D).

01/11/2024 Percutaneous Valvular and Structural Heart Disease Interventions. 2024 Core Curriculum of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC in collaboration with the European Association of Cardiovascular Imaging (EACVI) and the Cardiovascular Surgery Working Group (WG CVS) of the European Society of Cardiology

Teles, RC, Van Belle, E, Parma, R, Tarantini, G, Van Mieghem, N, Mylotte, D, Silva, JD, O'Connor, S, Sondegaard, L, Luz, A, Amat-Santos, IJ, Arzamendi, D, Blackman, D, De Backer, O, Kunadian, V, Buchanan, GL, MacCarthy, P, Lurz, P, Naber, C, Chieffo, A, Paradies, V, Gilard, M, Vincent, F, Fraccaro, C, Mehilli, J, Giannini, C, Silva, B, Poliacikova, P, Karam, N, Veulemans, V, Thiele, H, Pilgrim, T, van Wely, M, James, S, Schmidt, MR, Uebing, A, Rück, A, Ghanem, A, Ghazzal, Z, Joshi, FR, Favero, L, Hermanides, R, Ninios, V, Fovino, LN, Nuis, RJ, Deharo, P, Kala, P, Elbaz-Greener, G, Tchétché, D, Agricola, E, Thielmann, M, Donal, E, Bonaros, N, Droogmans, S, Czerny, M, Baumbach, A, Barbato, E, Dudek, D. Percutaneous Valvular and Structural Heart Disease Interventions. 2024 Core Curriculum of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC in collaboration with the European Association of Cardiovascular Imaging (EACVI) and the Cardiovascular Surgery Working Group (WG CVS) of the European Society of Cardiology. EuroIntervention. 2024; 20(22)DOI:10.4244/EIJ-D-23-00983. PMID:39207816. IF:9.500(Q1/1D).

01/11/2024 Comparing Outcomes Between Advanced Practice Providers and Housestaff Teams in the Cardiac Intensive Care Unit.

Zhang RS, Zhang P, Bailey E, Ho A, Rhee A, Xia Y, Schimmer H, Bernard S, Castillo P, Grossman K, Dai M, Singh A, Padilla-Lopez M, Nunemacher K, Hall SF, Rosenzweig B, Katz JN, Link N, Keller N, Bangalore S, Alviar CL. Comparing Outcomes Between Advanced Practice Providers and Housestaff Teams in the Cardiac Intensive Care Unit.. JACC-ADVANCES. 2024; 3(11)DOI:10.1016/j.jacadv.2024.101312. PMID:39569031. IF:(Q/D).

01/11/2024 A new perspective on the regulatory role of miRNAS. Cross-kingdom regulation

Sánchez-Quesada, JL. A new perspective on the regulatory role of miRNAS. Cross-kingdom regulation. Clinica E Investigacion En Arteriosclerosis. 2024; 36(6)DOI:10.1016/j.arteri.2024.10.003. PMID:39542529. IF:(Q/D).

01/11/2024 A post-hoc pooled analysis to evaluate efficacy and safety of insulin glargine 300 U/mL in insulin-naïve people with type 2 diabetes with/ without prior use of glucagon-like peptide-1 receptor agonist therapy

Cheng, AYY, Mauricio, D, Ritzel, R, Al-Sofiani, ME, Bailey, T, Mabunay, MA, Bonnemaire, M, Melas-Melt, L, Mimouni, S, Davies, M. A post-hoc pooled analysis to evaluate efficacy and safety of insulin glargine 300 U/mL in insulin-naïve people with type 2 diabetes with/ without prior use of glucagon-like peptide-1 receptor agonist therapy. DIABETES RESEARCH AND CLINICAL PRACTICE. 2024; 217DOI:10.1016/j.diabres.2024.111871. PMID:39343145. IF:7.400(Q1/1D).

01/11/2024 Persistence, effectiveness and safety of ustekinumab and vedolizumab therapy for complex perianal fistula in Crohn's disease: The HEAL study from GETECCU

Casanova, MJ, Caballol, B, García, MJ, Mesonero, F, de Célix, CR, Suárez-Alvarez, P, Ferreiro-Iglesias, R, Martín-Rodríguez, MDM, de Francisco, R, Varela-Trastoy, P, Bastida, G, Carrillo-Palau, M, Núñez-Ortiz, A, Ramírez-de la Piscina, P, Ceballos, D, Hervías-Cruz, D, Muñoz-Pérez, R, Velayos, B, Bermejo, F, Busquets, D, Cabacino, M, Camo-Monterde, P, Marín-Jiménez, I, Muñoz, C, de la Peña-Negro, LC, Sierra-Moros, E, Barrio, J, Brunet-Mas, E, Bujanda, L, Cañete, F, Gomollón, F, Manceñido-Marcos, N, Rodríguez-Lago, I, Rodríguez-Grau, MC, Sicilia, B, Torra-Alsina, S, Arranz-Hernández, L, Carpio, D, García-Sepulcre, MF, González-Muñoza, C, Huguet, JM, Márquez-Mosquera, L, López-Serrano, MP, Ponferrada-Díaz, A, Chaparro, M, Gisbert, JP. Persistence, effectiveness and safety of ustekinumab and vedolizumab therapy for complex perianal fistula in Crohn's disease: The HEAL study from GETECCU. DIGESTIVE AND LIVER DISEASE. 2024; 56(11)DOI:10.1016/j.dld.2024.05.009. PMID:38839456. IF:3.800(Q2/3D).

01/11/2024 Sex-Related Differences in the Phenotype and Course of Inflammatory Bowel Disease: SEXEII Study of ENEIDA

Gargallo-Puyuelo, CJ, Ricart, E, Iglesias, E, de Francisco, R, Gisbert, JP, Taxonera, C, Mañosa, M, Peris, MA, Navarrete-Muñoz, EM, Sanahuja, A, Guardiola, J, Mesonero, F, Tirado, MR, Barrio, J, Mendoza, IV, Parga, LD, García-Planella, E, Calvet, X, Arranz, MDM, García, S, Sicilia, B, Carpio, D, Domenech, E, Gomollón, F. Sex-Related Differences in the Phenotype and Course of Inflammatory Bowel Disease: SEXEII Study of ENEIDA. Clinical Gastroenterology and Hepatology. 2024; 22(11)DOI:10.1016/j.cgh.2024.05.013. PMID:38782172. IF:12.000(Q1/1D).

01/11/2024 Effectiveness Of Tocilizumab In Aortitis And Aneurysms Associated With Giant Cell Arteritis

Martín-Gutiérrez, A, Loricera, J, Narváez, J, Aldasoro, V, Maiz, O, Vela, P, Romero-Yuste, S, de Miguel, E, Galíndez-Agirregoikoa, E, Fernández-López, JC, Ferraz-Amaro, I, Sánchez-Martín, J, Moya, P, Campos, C, Lopez-Gutierrez, F, Castaneda, S, Blanco, R. Effectiveness Of Tocilizumab In Aortitis And Aneurysms Associated With Giant Cell Arteritis. European Journal of Internal Medicine. 2024; 129DOI:10.1016/j.ejim.2024.06.013. PMID:38908981. IF:6.100(Q1/1D).

01/11/2024 Comparative Analysis of Classification Criteria in IgG4-Related Disease and Evaluating Diagnostic Accuracy from a Retrospective Cohort in Clinical Practice

Lopez-Gomez, M, Moya-Alvarado, P, Park, HS, Martín, MC, Calleja, S, Codes-Mendez, H, Magallares, B, Castellví, I, Barros-Membrilla, AJ, Laiz, A, Diaz-Torné, C, Sainz, L, Bernárdez, J, Martínez-Martinez, L, Corominas, H. Comparative Analysis of Classification Criteria in IgG4-Related Disease and Evaluating Diagnostic Accuracy from a Retrospective Cohort in Clinical Practice. Diagnostics. 2024; 14(22)DOI:10.3390/diagnostics14222583. PMID:39594249. IF:3.300(Q1/2D).

01/11/2024 Mycobacterium branderi Diagnosed by CryoEBUS. A New Tool for Infection Diagnosis?

Codern, AR, Ruiz, VP, Mitjà, PS. Mycobacterium branderi Diagnosed by CryoEBUS. A New Tool for Infection Diagnosis?. ARCHIVOS DE BRONCONEUMOLOGIA. 2024; 60(11)DOI:10.1016/j.arbres.2024.06.012. PMID:39013726. IF:9.200(Q1/1D).

01/11/2024 Asthma Control According to GINA 2023: Does Changing the Criteria Improve Asthma Control?

Arismendi, E, Ribo, P, Garcia, A, Torrego, A, Bobolea, I, Casas-Saucedo, R, Palomino, R, Picado, C, Muñoz-Cano, R, Valero, A. Asthma Control According to GINA 2023: Does Changing the Criteria Improve Asthma Control?. Journal of Clinical Medicine. 2024; 13(22)DOI:10.3390/jcm13226646. PMID:39597790. IF:2.900(Q1/2D).

01/11/2024 Walking one hour per day and the derived neutrophil-to-lymphocyte ratio are associated with outcome in palliative second-line immunotherapy for patients with recurrent and/or metastatic squamous cell carcinoma of head and neck

Caballero-Borrego, M, Piedra, A, Gallego, O, López-Pousa, A, Castillo, P, Navarrete, P, Prat, A, Grau, JJ. Walking one hour per day and the derived neutrophil-to-lymphocyte ratio are associated with outcome in palliative second-line immunotherapy for patients with recurrent and/or metastatic squamous cell carcinoma of head and neck. Brazilian Journal of Otorhinolaryngology. 2024; 90(6)DOI:10.1016/j.bjorl.2024.101493. PMID:39205362. IF:1.800(Q2/4D).

01/11/2024 Eftilagimod Alpha (a Soluble LAG-3 Protein) Combined With Pembrolizumab in Second-Line Metastatic NSCLC Refractory to Anti-Programmed Cell Death Protein 1/Programmed Death-Ligand 1-Based Therapy: Final Results from a Phase 2 Study

Krebs, MG, Forster, M, Majem, M, Peguero, J, Iams, W, Clay, T, Roxburgh, P, Doger, B, Bajaj, P, Barba, A, Perera, S, Mueller, C, Triebel, F. Eftilagimod Alpha (a Soluble LAG-3 Protein) Combined With Pembrolizumab in Second-Line Metastatic NSCLC Refractory to Anti-Programmed Cell Death Protein 1/Programmed Death-Ligand 1-Based Therapy: Final Results from a Phase 2 Study. Jto Clinical And Research Reports. 2024; 5(11)DOI:10.1016/j.jtocrr.2024.100725. PMID:39403626. IF:(Q/D).

01/11/2024 Perioperative chemotherapy and nivolumab in non-small-cell lung cancer (NADIM): 5-year clinical outcomes from a multicentre, single-arm, phase 2 trial

Provencio, M, Nadal, E, Insa, A, Campelo, RG, Casal, J, Dómine, M, Massuti, B, Majem, M, Rodríguez-Abreu, D, Martínez-Marti, A, de Castro, J, de Antonio, DG, Macia, I, Figueroa, S, Vago, LF, Calvo, V, Palmero, R, Sierra-Rodero, B, Martínez-Toledo, C, Molina-Alejandre, M, Serna-Blasco, R, Romero, A, Cruz-Bermúdez, A. Perioperative chemotherapy and nivolumab in non-small-cell lung cancer (NADIM): 5-year clinical outcomes from a multicentre, single-arm, phase 2 trial. LANCET ONCOLOGY. 2024; 25(11)DOI:10.1016/S1470-2045(24)00498-4. PMID:39419061. IF:35.900(Q1/1D).

01/11/2024 Recommendations on the Treatment of Metastatic Hormone-Sensitive Prostate Cancer: Patient Selection

Borque-Fernando, A, Zapatero, A, Manneh, R, Alonso-Gordoa, T, Couñago, F, Domínguez-Esteban, M, López-Valcárcel, M, Rodríguez-Antolín, A, Sala-González, N, Sanmamed, N, Maroto, P. Recommendations on the Treatment of Metastatic Hormone-Sensitive Prostate Cancer: Patient Selection. Actas Urologicas Espanolas. 2024; 48(9)DOI:10.1016/j.acuro.2024.03.002. PMID:38740263. IF:1.200(Q3/7D).

01/11/2024 Longitudinal Analyses of Circulating Tumor DNA for the Detection of EGFR Mutation-Positive Advanced NSCLC Progression During Treatment: Data From FLAURA and AURA3

Gray, JE, Markovets, A, Reungwetwattana, T, Majem, M, Nogami, N, Peled, N, Lee, JS, Cho, BC, Chewaskulyong, B, John, T, Han, JY, Sebastian, M, Todd, A, Rukazenkov, Y, Barrett, C, Chmielecki, J, Lee, SM, Ramalingam, SS, Hartmaier, R. Longitudinal Analyses of Circulating Tumor DNA for the Detection of EGFR Mutation-Positive Advanced NSCLC Progression During Treatment: Data From FLAURA and AURA3. Journal of Thoracic Oncology. 2024; 19(11)DOI:10.1016/j.jtho.2024.07.008. PMID:39029876. IF:20.800(Q1/1D).

01/11/2024 Development of a prognostic model to predict 90-day mortality in hospitalised cancer patients (PROMISE tool): a prospective observational study

Mirallas, O, Martin-Cullell, B, Navarro, V, Vega, KS, Recuero-Borau, J, Gómez-Puerto, D, López-Valbuena, D, de Torres, CS, Andurell, L, Pedrola, A, Berché, R, Palmas, F, Ucha, JM, Villacampa, G, Rezqallah, A, Sanz-Beltran, J, Bach, R, Bueno, S, Viaplana, C, Molina, G, Hernando-Calvo, A, Aguilar-Company, J, Roca, M, Muñoz-Couselo, E, Martínez-Martí, A, Alonso, A, Eremiev, S, Macarulla, T, Oaknin, A, Saura, C, Élez, E, Felip, E, Peñuelas, A, Burgos, R, Pardo, PG, Garralda, E, Tabernero, J, Serradell, S, Servitja, S, Paez, D, Dienstmann, R, Carles, J. Development of a prognostic model to predict 90-day mortality in hospitalised cancer patients (PROMISE tool): a prospective observational study. Lancet Regional Health-Europe. 2024; 46DOI:10.1016/j.lanepe.2024.101063. PMID:39529819. IF:13.000(Q1/1D).

01/11/2024 The current situation of tutoring in specialised training in otorhinolaryngology-head and neck surgery in Spain. Where are we? Where do we want to go?

Canduela, PDD, Jurado, FXA, Beltrán, JD, Ruiz, CM, Gadea, AS, López, F. The current situation of tutoring in specialised training in otorhinolaryngology-head and neck surgery in Spain. Where are we? Where do we want to go?. Acta Otorrinolaringologica Espanola. 2024; 75(6)DOI:10.1016/j.otorri.2024.03.002. PMID:. IF:(Q/D).

01/11/2024 Evaluating the effect of passive cooling strategies in school buildings on children's well-being in Barcelona: A quasi-experimental, mixed methods study

Sanz-Mas, M, Continente, X, Brugueras, S, Marí-Dell'Olmo, M, Oliveras, L, López, MJ. Evaluating the effect of passive cooling strategies in school buildings on children's well-being in Barcelona: A quasi-experimental, mixed methods study. The Science of the total environment. 2024; 949DOI:10.1016/j.scitotenv.2024.175104. PMID:39079644. IF:8.000(Q1/2D).

01/11/2024 Elective splenectomy for hematological diseases: a vanishing indication

Fernández-Ananin, S, Novelli, S, Cabré, LC, Riera, CV, Vàzquez, EB, Verdaguer, EJ, Targarona, EM. Elective splenectomy for hematological diseases: a vanishing indication. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES. 2024; 38(11)DOI:10.1007/s00464-024-11071-8. PMID:39210059. IF:2.700(Q1/3D).

01/11/2024 Effectiveness of official food safety control in Barcelona city: Digital and traditional inspections

Grau-Noguer, E, Rodríguez-Sanz, M, Suppi, R, Serratosa, J, Lundén, J, Bolao, A, Cedano, D, Portaña, S. Effectiveness of official food safety control in Barcelona city: Digital and traditional inspections. FOOD CONTROL. 2024; 165DOI:10.1016/j.foodcont.2024.110655. PMID:. IF:6.300(Q1/2D).

01/11/2024 Strategies for the prevention and non-pharmacological treatment of obesity. Models of care

Rosales, A, Mendoza, L, Minambres, I. Strategies for the prevention and non-pharmacological treatment of obesity. Models of care. Atencion Primaria. 2024; 56(11)DOI:10.1016/j.aprim.2024.102978. PMID:38820670. IF:1.600(Q2/4D).

01/11/2024 Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortality in patients with MASLD

Paternostro, R, Kwanten, WJ, Hofer, BS, Semmler, G, Bagdadi, A, Luzko, I, Hernández-Gea, V, Graupera, I, García-Pagán, JC, Saltini, D, Indulti, F, Schepis, F, Moga, L, Rautou, PE, Llop, E, Téllez, L, Albillos, A, Fortea, JI, Puente, A, Tosetti, G, Primignani, M, Zipprich, A, Vuille-Lessard, E, Berzigotti, A, Taru, MG, Taru, V, Procopet, B, Jansen, C, Praktiknjo, M, Gu, WY, Trebicka, J, Ibanez-Samaniego, L, Bañares, R, Rivera-Esteban, J, Pericas, JM, Genesca, J, Alvarado, E, Villanueva, C, Larrue, H, Bureau, C, Laleman, W, Ardevol, A, Masnou, H, Vanwolleghem, T, Trauner, M, Mandorfer, M, Francque, S, Reiberger, T. Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortality in patients with MASLD. JOURNAL OF HEPATOLOGY. 2024; 81(5)DOI:10.1016/j.jhep.2024.05.033. PMID:38823501. IF:33.000(Q1/1D).

01/11/2024 Transcatheter Aortic Valve Replacement: Latest Advances and Prospects

Asmarats, L, Arzamendi, D. Transcatheter Aortic Valve Replacement: Latest Advances and Prospects. Journal of Clinical Medicine. 2024; 13(21)DOI:10.3390/jcm13216583. PMID:39518721. IF:2.900(Q1/2D).

01/11/2024 SEOM clinical guidelines for cancer anorexia-cachexia syndrome (2023).

Soria Rivas A, Escobar Álvarez Y, Blasco Cordellat A, Majem Tarruella M, Molina Mata K, Motilla de la Cámara M, Del Mar Muñoz Sánchez M, Zafra Poves M, Beato Zambrano C, Cabezón Gutierrez L. SEOM clinical guidelines for cancer anorexia-cachexia syndrome (2023).. Clinical & Translational Oncology. 2024; 26(11)DOI:10.1007/s12094-024-03502-8. PMID:38822976. IF:(Q/D).

30/10/2024 Dupilumab treatment in paediatric atopic dermatitis (2-18 years): Spanish multicentre retrospective real-world study

Iznardo, H, Roé, E, Vicente, A, Prat, C, Casals, M, Martín-Santiago, A, Esteve, A, Viñas, M, Munera-Campos, M, Corella, F, Mollet, J, Figueras-Nart, I, Vila, A, Soria, X, Azón-Masoliver, A, Marqués-Martín, L, Nadal-Lladó, C, Bel, S, Pujol-Montcusí, J, Bertolín-Colilla, M, Curto-Barredo, L, Melé-Ninot, G, Evole, M, Berbegal, L, Puig, L, Baselga, E. Dupilumab treatment in paediatric atopic dermatitis (2-18 years): Spanish multicentre retrospective real-world study. CLINICAL AND EXPERIMENTAL DERMATOLOGY. 2024; 50(1)DOI:10.1093/ced/llae300. PMID:39093288. IF:2.800(Q2/4D).

29/10/2024 BRIVA-ONE study: 12-month outcomes of brivaracetam monotherapy in clinical practice

Villanueva, V, Villar, EG, Fernandez-Cabrera, A, Zurita, J, Lopez-Gonzalez, FJ, Rodríguez-Osorio, X, Parejo-Carbonell, B, Estevez, JC, Mercedes-Alvarez, B, Ojeda, J, Rubio-Roy, M, Garcia-Escrivá, A, Gómez-Ibáñez, A, Martinez-Poles, J, Martinez-Agredano, P, Calle, R, Sierra-Marcos, A, Gonzalez, AM, Herrera, JD, Rodriguez-Uranga, J, Cabezas, B, Martinez, E, Renau, J, de Toledo, M, Hampel, KG, Alarcón, C, Barceló, MI, Monterde, A, Lara, LB, Sansa, G, Serratosa, JM. BRIVA-ONE study: 12-month outcomes of brivaracetam monotherapy in clinical practice. Epilepsia Open. 2024; 9(6)DOI:10.1002/epi4.13078. PMID:39470722. IF:2.900(Q2/4D).